Table 1 Study cohort characteristics by affordable care act implementation timepoints (n = 170,690)a
Pre-ACA | Post-ACA | Overall | |
|---|---|---|---|
1/1/12–12/31/14 | 1/1/15 − 12/31/18 | 1/1/12–12/31/18 | |
(n = 50,964) | (n = 119,726) | (n = 170,690) | |
Variable | No. (%) | No. (%) | No. (%) |
Perinatal Mood and Anxiety Disorder (PMAD) Diagnosis Rate | |||
PMAD Diagnosis | 6443 (12.6%) | 20,108 (16.8%) | 26,551 (15.6%) |
No PMAD Diagnosis | 44,521 (87.4%) | 99,618 (83.2%) | 144,139 (84.4%) |
Any Treatment Rate | |||
Treatment | 11,077 (21.7%) | 30,490 (25.5%) | 41,567 (24.4%) |
No Treatment | 39,887 (78.3%) | 89,236 (74.5%) | 129,123 (75.6%) |
Prescription Medication Rate | |||
Prescription Medication | 9542 (18.7%) | 25,574 (21.4%) | 35,116 (20.6%) |
No Prescription Medication | 41,422 (81.3%) | 94,152 (78.6%) | 135,574 (79.4%) |
Psychotherapy Rate | |||
Psychotherapy | 3347 (6.6%) | 10,773 (9.0%) | 14,120 (8.3%) |
No Psychotherapy | 47,617 (93.4%) | 108,953 (91.0%) | 156,570 (91.7%) |
Age at delivery (years) | |||
< 26 years | 25,107 (49.3%) | 52,573 (43.9%) | 77,680 (45.5%) |
≥ 26 years | 25,857 (50.7%) | 67,153 (56.1%) | 93,010 (54.5%) |
Race/ethnicity | |||
White | 32,037 (62.9%) | 71,718 (59.9%) | 103,755 (60.8%) |
Non-white/Unknown | 18,927 (37.1%) | 48,008 (40.1%) | 66,935 (39.2%) |
OBCMI Score | |||
OBCMI score ≤ 2 | 45,083 (88.5%) | 98,933 (82.6%) | 144,016 (84.4%) |
OBCMI score > 2 | 5881 (11.5%) | 20,793 (17.4%) | 26,674 (15.6%) |